Cell and Gene Therapy and the Biologic Therapy Market
Cell and gene therapies represent the most ambitious frontier of the biologic therapy market. Rather than managing symptoms, these treatments aim to correct disease at its genetic or cellular source — potentially offering one-time cures for conditions that previously required lifelong management. CAR-T therapies for blood cancers, gene therapies for inherited disorders, and emerging...